AI supports instant diagnosis of top eye disease
Artificial intelligence is being used to support the instant diagnosis of diabetic retinopathy, one of the top causes of blindness, in its earliest stages.
With no early-stage symptoms, the disease may already be advanced by the time people start losing their sight. Early diagnosis and treatment can make a dramatic difference to how much vision a patient retains.
Now a team of Australian–Brazilian researchers led by RMIT University have developed an image-processing algorithm that can automatically detect one of the key signs of the disease, fluid on the retina, with an accuracy rate of 98%.
Lead investigator Professor Dinesh Kant Kumar, from RMIT, said the method was instantaneous and cost-effective.
“We know that only half of those with diabetes have regular eye exams and one-third have never been checked,” Prof Kumar said. “But the gold standard methods of diagnosing diabetic retinopathy are invasive or expensive, and often unavailable in remote or developing parts of the world.
“Our AI-driven approach delivers results that are just as accurate as clinical scans but relies on retinal images that can be generated with ordinary optometry equipment.
“Making it quicker and cheaper to detect this incurable disease could be life-changing for the millions of people who are currently undiagnosed and risk losing their sight.”
Fluorescein angiography and optical coherence tomography scans are currently the most accurate clinical methods for diagnosing diabetic retinopathy.
An alternative and cheaper method is analysing images of the retina that can be taken with relatively inexpensive equipment called fundus cameras, but the process is manual, time-consuming and less reliable.
To automate the analysis of fundus images, researchers in the Biosignals Laboratory in the School of Engineering at RMIT, together with collaborators in Brazil, used deep learning and artificial intelligence techniques. The algorithm they developed can accurately and reliably spot the presence of fluid from damaged blood vessels, or exudate, inside the retina.
The researchers hope their method could eventually be used for widespread screening of at-risk populations.
“Undiagnosed diabetes is a massive health problem here and around the globe,” Prof Kumar said.
“For every single person in Australia who knows they have diabetes, another is living with diabetes but isn’t diagnosed. In developing countries, the ratio is one diagnosed to four undiagnosed.
“This results in millions of people developing preventable and treatable complications from diabetes-related diseases.
“With further development, our technology has the potential to reduce that burden.”
The researchers are in discussion with manufacturers of fundus cameras about potential collaborations to advance the technology.
A team of metabolism scientists at the University of Wisconsin-Madison and the Morgridge...
BreastScreen Victoria (BSV), the Victorian Government's breast cancer screening organisation,...
RMIT University, Telstra Health and the Digital Health CRC are partnering to develop analytical...